Cyclosporin a therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow

British Journal of Haematology

Volumn 100, Issue 2, 1998, Pages 304-309

  Jonásová, Anna ^a,e   Nnuwirtova, Radana ^a   Cermák, Jaroslav ^b   Vozobulová, Vêra ^a   Mocikovä, Katarina ^c   Siaková, Magda ^d   Hocuová, Ivana ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Institute of Clinical Haematology   (Czech Republic)

^c Fakultna nemocnica s poliklinikou FD Roosevelta Banska Bystrica   (Slovakia)

^d UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^e NONE   (United States)

Author keywords

Autoimmunity; Cyclosporin A therapy; Hypoplastic MDS; Myelodysplastic syndrome RA

Indexed keywords

ANDROGEN; CORTICOSTEROID; CYANOCOBALAMIN; CYCLOSPORIN A; CYTARABINE; DANAZOL; ERYTHROPOIETIN; FOLIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; PYRIDOXINE;

ADULT; AGED; ANEMIA; ARTICLE; AUTOIMMUNITY; BLOOD TRANSFUSION; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; FEMALE; HEMATOLOGIC DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; LIVER DISEASE; MALE; MYELODYSPLASTIC SYNDROME; NAUSEA; PARESTHESIA; PRIORITY JOURNAL; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA, REFRACTORY; BLOOD CELL COUNT; BONE MARROW; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0031888417     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00551.x     Document Type: Article

References (18)

1. Bennett, J.M., Catovsky, D.. Daniel. M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R., Sultan, C., and the French-Amcrican-British (FAB) Co-operative Group (1982) Proposals for the classification of the myelodysplastic syndromes. British Journal ofllacinatology, 51, 189-199.
2. Bouscary, D., De Vos. J., Guesnu, M., Viguier, F., Meile, J., Picard. F.. Dreyfus. F. & Fontenay-Roupie, M. (1997) Apoptosis and Fas antigen expression in myelodysplasia. Fourth International Symposium on MDS. leukemia Research, 21, 26-27.
3. Editorial (1985) Cyclosporin in autoimmune disease. Lancet, i. 909211.
4. Enright, H., Jacob, S.U., Vercellotti, G., Howe, R., Beizer, M. & Miller. W. (1995) Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy. British Journal of Haematology, 91,403-408.
5. Fohlmeister, L, Fischer, R.. Modder, B.. Rister. M. & Schaefer, H-E. (1985) Aplastic anaemia and the hypocellular myelodysplastic syndrome: histomorphological diagnostic, and prognostic features. Journal of Clinical Pathology, 38, 1218-1224.
6. Hamblin. T.J. (1996) Immunological abnormalities in myelodysplastic syndromes. Seminars in Hematology. 33, 150-162.
7. Imai. Y., Fukuoka, T., Nakatani, A., Ohsaka, A. & Takahashi. A. (1996) Sustained trilineage recovery and disappearance of abnormal chromosome clone in a patient with myelodysplastic syndrome following combination therapy with cytokines (granulocyte colony-stimulating factor and erythropoietin) and high-dose methylprednisolone. British Journal of Haematology, 93, 146-150.
8. Kouides, P.A. & Bennett, J.M. (1996) Morphology and classification of myelodysplastic syndromes and their pathologic variants. Seminars in Hematology, 33, 95-110.
9. Maschek, H., Kaloutsi, V, Rodriguez-Kaiser, M., Werner, M., Choritz, H., Maizner, K., Dietzfelbinger, M. & Georgi, A. (1993) Hypoplastic myelodysplastic syndrome: incidence, morphology, cytogenetics, and prognosis. Annals of Hematology, 66, 117-122.
10. Miescher. P.A., Favre, H. & Beris, P. (1991) Autoimmune myelodysplasias. Seminars in Hematology, 28, 322-330.
11. Mufti, G.J., Figes, A., Hamblin, T.J., Oscier, D.G. & Copplestone, J.A. (1986) Immunological abnormalities in myelodysplastic syndromes. British Journal of Haematology, 63, 143-147.
12. Muller, E.W.. De Wolfe. J.Th.M. & Vellenga, E. (1993) Successful immunosuppressive treatment after failure of erythropoietin therapy in two subjects with refractory anaemia. British Journal of Haematology, 83, 171-172.
13. Neuwirtova. R., Mocikova, K., Jelinek, J.. Musilova, J., Havlicek. F., Michalova, K. & Adamko, M. (1996) Mixed myelodysplasic and myeloproliferative syndromes. Leukemia Research, 20, 717-723.
14. Raza, A., Gezer, S., Mundle, S., Gao, X., Alvi, S., Borok, R., Rilkin, S., Iftikhal, VS., Parcharidou, A., Loew, J., Marcus, B., Khan, Z., Chancy, C.. Showel. J.. Gregory, S. & Preisler. H. (1995) Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood, 86, 268-276.
15. Ricciardi, M.R., Petrucci, M.T., Ariola, C., Gregor], C.. Latagliate, R., Petti, M.C. & Tafuri, A. (1997) CD34 cells in MDS with lower percentage of blasts are characterized by high spontaneous rate of apoptosis. Fourth International Symposium on MDS. Leukemia Research, 21,27.
16. Trucco, M., Rovera, G. & Ferrero, D. (1984) A novel human lymphokine that inhibits haematopoietic progenitor cell prolifera-tion. Katun, 309, 166-168.
17. Tuzuner, N., Cox, C., Rowe, J.M.. Watrous, D. & Bennett, J.M. (1995) Hypocellular myelodysplastic syndromes (MDS): new proposals. British Journal of Haematology, 91, 612-617.
18. Young, N.S. (1992) The problem of clonality in aplastic anemia. Blood. 79. 1385-1392.